Skip to main content

Table 1 Demographic and baseline characteristics

From: Surveillance for the safety and effectiveness of artemether-lumefantrine in patients with uncomplicated Plasmodium falciparum malaria in the USA: a descriptive analysis

Characteristic

N = 203a

Age (years)

 Mean ± SD

34.2 ± 18.5

 Median

32

 Range

1–88

Age (years) category, n (%)

 ≤16

32 (15.8)

 17–64

157 (77.3)

 ≥65

14 (6.9)

Gender, n (%)

 Male

119 (58.6)

 Female

84 (41.4)

Race, n (%)

 Black or African American

127 (62.6)

 Caucasian

55 (27.1)

 Asian

9 (4.4)

 Native Hawaiian or Other Pacific Islander

2 (1.0)

 American Indian or Alaska Native

1 (0.5)

 Missing

9 (4.4)

Ethnicity, n (%)

 Hispanic or Latino

2 (1.0)

 Not Hispanic or Latino

188 (92.6)

 Missing

13 (6.4)

Height (cm), N = 109

 Mean ± SD

165.7 ± 21.8

 Median

172.7

 Range

80.0–198.1

Weight (kg), N = 132

 Mean ± SD

71.1 ± 23.8

 Median

72.7

 Range

9.0–144.1

BMI (kg/m2), N = 107

 Mean ± SD

25.6 ± 5.9

 Median

25.5

 Range

13.8–42.4

BMI (kg/m2) category, n (%)

 <25

50 (24.6)

 ≥25

57 (28.1)

 Missing

96 (47.3)

Immune status, n (%)

 Likely non-immune

164 (80.8)

 Likely semi-immune

39 (19.2)

Malaria species, n (%)

 P. falciparum

160 (78.8)

 Other Plasmodium species (including P. vivax, P. ovale, P. malariae)

26 (12.8)

 Undetermined

17 (8.4)

Malaria diagnosis, n (%)

 Confirmed by microscopy

195 (96.1)

 Confirmed by PCR

6 (3.0)

 Suspected

1 (0.5)

 RDT positive (microscopy negative)

1 (0.5)

  1. BMI, body mass index, calculated in kg/m2 as weight (in pounds) × 703/(height)2 (in inches); SD, standard deviation
  2. aN = 203 unless indicated otherwise